Aberrant neural activity in prefrontal pyramidal neurons lacking TDP-43 precedes neuron loss.
Ruby, Hyrum P
Wong, Philip C
JournalProgress in Neurobiology
MetadataShow full item record
AbstractMislocalization of TAR DNA binding protein 43 kDa (TARDBP, or TDP-43) is a principal pathological hallmark identified in cases of neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). As an RNA binding protein, TDP-43 serves in the nuclear compartment to repress non-conserved cryptic exons to ensure the normal transcriptome. Multiple lines of evidence from animal models and human studies support the view that loss of TDP-43 leads to neuron loss, independent of its cytosolic aggregation. However, the underlying pathogenic pathways driven by the loss-of-function mechanism are still poorly defined. We employed a genetic approach to determine the impact of TDP-43 loss in pyramidal neurons of the prefrontal cortex (PFC). Using a custom-built miniscope imaging system, we performed repetitive in vivo calcium imaging from freely behaving mice for up to 7 months. By comparing calcium activity in PFC pyramidal neurons between TDP-43 depleted and TDP-43 intact mice, we demonstrated remarkably increased numbers of pyramidal neurons exhibiting hyperactive calcium activity after short-term TDP-43 depletion, followed by rapid activity declines prior to neuron loss. Our results suggest aberrant neural activity driven by loss of TDP-43 as the pathogenic pathway at early stage in ALS and FTD.
Rights/TermsCopyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
KeywordAberrant neural activity
In vivo calcium imaging
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19216
- Quantitative analysis of cryptic splicing associated with TDP-43 depletion.
- Authors: Humphrey J, Emmett W, Fratta P, Isaacs AM, Plagnol V
- Issue date: 2017 May 26
- Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
- Authors: McCann EP, Fifita JA, Grima N, Galper J, Mehta P, Freckleton SE, Zhang KY, Henden L, Hogan AL, Chan Moi Fat S, Wu SS, Jagaraj CJ, Berning BA, Williams KL, Twine NA, Bauer D, Piguet O, Hodges J, Kwok JBJ, Halliday GM, Kiernan MC, Atkin J, Rowe DB, Nicholson GA, Walker AK, Blair IP, Yang S
- Issue date: 2020 Feb
- Upregulation of ATG7 attenuates motor neuron dysfunction associated with depletion of TARDBP/TDP-43.
- Authors: Donde A, Sun M, Jeong YH, Wen X, Ling J, Lin S, Braunstein K, Nie S, Wang S, Chen L, Wong PC
- Issue date: 2020 Apr
- Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
- Authors: Barmada SJ, Finkbeiner S
- Issue date: 2010
- TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.
- Authors: Ling JP, Pletnikova O, Troncoso JC, Wong PC
- Issue date: 2015 Aug 7